Peptide therapeutics companies develop medicines built from short chains of amino acids designed to interact with specific biological targets. These molecules can combine high target selectivity with formats suited to a wide range of therapeutic applications.
This category includes companies working on:
Browse 36 UK peptide therapeutics companies below.
Therapeutic cancer vaccines based on recombinant overlapping peptide technology
Oxford Vacmedix is a clinical-stage biopharma company developing therapeutic cancer vaccines using its proprietary Recombinant Overlapping Peptide (ROP) platform. ROPs stimulate…
Integrated chemistry and development CRO for small molecules
CatSci is a Cardiff-headquartered contract research organisation providing integrated chemistry, analytical, and development services to biotech and pharmaceutical companies.…
Peptide immunotherapies for the treatment of food allergy
Aravax is a clinical-stage biotechnology company developing next-generation specific immunotherapies for food allergy. Its lead candidate, PVX108, is a synthetic peptide-based…
Novel peptide therapeutics targeting obesity and type 2 diabetes
Dia Beta Labs is a preclinical-stage biotechnology company developing first-in-class therapeutic peptides for metabolic disease. Spun out of the Diabetes Research Group at Ulster…
Synthetic T cell-priming vaccines and immunotherapies for infectious disease
Gylden Pharma is a clinical-stage biotechnology company developing 100% synthetic T cell-priming vaccines and immunotherapies. Its nanoparticle platform delivers synthetic…
Whole genome synthesis platform engineering novel therapeutic biomolecules
Constructive Bio is a Cambridge-based synthetic biology company developing programmable biology platforms for the creation of novel biomolecules. Spun out of the MRC Laboratory of…
Engineered hybrid interferon therapeutics for viral and immune-mediated disease
ILC Therapeutics is a pre-clinical biotechnology company developing hybrid interferons, an engineered cytokine drug class combining favourable attributes of multiple naturally…
GPCR-targeting ophthalmic therapeutics for dry eye and corneal pain
OKYO Pharma is a clinical-stage biopharmaceutical company developing treatments for inflammatory eye diseases and chronic ocular pain. Its lead candidate, urcosimod, is a…
Constrained bicyclic peptide conjugates for targeted cancer therapy
Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of therapeutics based on short synthetic peptides constrained by a small molecule…
Manufacturer of small molecule and peptide reagents for life science research
Tocris Bioscience is a manufacturer and supplier of high-purity small molecule and peptide research reagents serving the global life science community. Its catalogue of over 4,500…
Clinical-stage peptide therapeutics for autoimmune and infectious disease
ImmuPharma is a clinical-stage biopharmaceutical company developing peptide-based therapeutics and precision diagnostics for autoimmune disease, infectious disease and metabolic…
Cyclic peptide screening platform for first-in-class cancer drugs
Curve Therapeutics is a drug discovery company using its proprietary platform to identify first-in-class small molecule therapeutics against targets that have been difficult to…